Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma

European Journal of Cancer Prevention

Volumn 21, Issue 6, 2012, Pages 569-575

  He, Dan ^a   Zeng, Quan ^a   Ren, Guosheng ^a   Xiang, Tingxiu ^a   Qian, Yi ^a   Hu, Qin ^a   Zhu, Jiang ^a   Hong, Suling ^a   Hu, Guohua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Methylation; Nasopharyngeal carcinoma; Protocadherin8; Tumor suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; PROTOCADHERIN 8; TRICHOSTATIN A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARCINOMA CELL; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIGRATION INHIBITION; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION;

APOPTOSIS; AZACITIDINE; CADHERINS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXAMIC ACIDS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; WOUND HEALING;

EID: 84866896681     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328350b097     Document Type: Article

References (30)

1. Chan SL, Cui Y, Van Hasselt A, Li H, Srivastava G, Jin H, et al. (2007). The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab Invest 87:644-650.
2. Cheng Y, Geng H, Cheng SH, Liang P, Bai Y, Li J, et al. (2010). KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. Cancer Res 70:6516-6526.
3. Haruki S, Imoto I, Kozaki K, Matsui T, Kawachi H, Komatsu S, et al. (2010). Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma. Carcinogenesis 31:1027-1036.
4. Imoto I (2006). Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Cancer Res 66:4617-4626.
5. Jin H, Wang X, Ying J, Wong AHY, Li H, Lee KY, et al. (2007). Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Oncogene 26:7490-7498.
6. Jones PA, Baylin SB (2007). The epigenomics of cancer. Cell 128:683-692.
7. Kim SY, Yasuda S, Tanaka H, Yamagata K, Kim H (2011). Non-clustered protocadherin. Cell Adh Migr 5:97-105.
8. Leshchenko VV, Kuo PY, Shaknovich R, Yang DT, Gellen T, Petrich A, et al. (2010). Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood 116:1025-1034.
9. Lo KW, To KF, Huang DP (2004). Focus on nasopharyngeal carcinoma. Cancer Cell 5:423-428.
10. Morishita H, Yagi T (2007). Protocadherin family: diversity, structure, and function. Curr Opin Cell Biol 19:584-592.
11. Morris MR, Ricketts CJ, Gentle D, McRonald F, Carli N, Khalili H, et al. (2010). Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene 30:1390-1401.
12. Narayan G, Scotto L, Neelakantan V, Kottoor SH, Wong AHY, Loke S-L, et al. (2009). Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes, Chromosomes Cancer 48:983-992.
13. Qiu G-H, Tan LKS, Loh KS, Lim CY, Srivastava G, Tsai S-T, et al. (2004). The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 23:4793-4806.
14. Seng TJ, Low JSW, Li H, Cui Y, Goh HK, Wong MLY, et al. (2006). The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 26:934-944.
15. Suzuki H, Gabrielson E, ChenW, Anbazhagan R, Van Engeland M,Weijenberg MP, et al. (2002). A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31:141-149.
16. Tao Q, Swinnen LJ, Yang J, Srivastava G, Robertson KD, Ambinder RF (1999). Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease: application of PCR-based analysis. Am J Pathol 155:619-625.
17. Tao Q, Huang H, Geiman TM, Lim CY, Fu L, Qiu GH, et al. (2002). Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet 11:2091-2102.
18. Tao Q, Chan ATC (2007). Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Exp Rev Mol Med 9:644-650.
19. Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, Zheng Z, et al. (2002). Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 1590:150-158.
20. Wei WI, Sham JS (2005). Nasopharyngeal carcinoma. Lancet 365:2041-2054.
21. Williams S, Ying Y, Cui Y, Van Hasselt A, Ng KM, Yu J, et al. (2008). OPCML Is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS ONE 3:e2990.
22. Yagi T (2008). Clustered protocadherin family. Develop Growth Differentiation 50:S131-S140.
23. Ying J (2005). The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res 11:6442-6449.
24. Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, et al. (2006). Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 25:1070-1080.
25. Ying J, Gao Z, Li H, Srivastava G, Murray PG, Goh HK, et al. (2007). Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. Br J Haematol 136:829-832.
26. Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, et al. (2008a). Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 48:508-518.
27. Yu J, Cheng YY, Tao Q, Cheung KF, Lam CNY, Geng H, et al. (2009). Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 136:640-651, .e641.
28. Yu JS, Koujak S, Nagase S, Li CM, Su T, Wang X, et al. (2008b). PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene 27:4657-4665.
29. Yu MC, Yuan JM (2002). Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12:421-429.
30. Zhou MG, Wang XF, Hu JP, Li GL, Chen WQ, Zhang SW, et al. (2010). Geographical distribution of cancer mortality in China, 2004-2005. Zhonghua Yu Fang Yi Xue Za Zhi 44:303-308.